Global Meningococcal Polysaccharide Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 92
Published Date: 11 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Meningococcal Polysaccharide Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Meningococcal polysaccharide diphtheria conjugate vaccine is an active immunizing agent used to prevent infection by certain groups of meningococcal bacteria.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Meningococcal Polysaccharide Vaccine industry chain, the market status of 6 Months-15Year (Polysaccharide Meningtitis AC, Meningitis ACYW), over 3 Year (Polysaccharide Meningtitis AC, Meningitis ACYW), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Meningococcal Polysaccharide Vaccine.
Regionally, the report analyzes the Meningococcal Polysaccharide Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Meningococcal Polysaccharide Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Meningococcal Polysaccharide Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Meningococcal Polysaccharide Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., Polysaccharide Meningtitis AC, Meningitis ACYW).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Meningococcal Polysaccharide Vaccine market.
Regional Analysis: The report involves examining the Meningococcal Polysaccharide Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Meningococcal Polysaccharide Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Meningococcal Polysaccharide Vaccine:
Company Analysis: Report covers individual Meningococcal Polysaccharide Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Meningococcal Polysaccharide Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (6 Months-15Year, over 3 Year).
Technology Analysis: Report covers specific technologies relevant to Meningococcal Polysaccharide Vaccine. It assesses the current state, advancements, and potential future developments in Meningococcal Polysaccharide Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Meningococcal Polysaccharide Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Meningococcal Polysaccharide Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Polysaccharide Meningtitis AC
Meningitis ACYW
Market segment by Application
6 Months-15Year
over 3 Year
over 2 Year
over 3 Months
Major players covered
Sanofi
Bio-Med
CanSinoBIO
Walvax Biotechnology
Chongqing Zhifei Biological
Chengdu Kanghua Biological Products
Changsheng Biotechnology
CanSinoBIO
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Meningococcal Polysaccharide Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Meningococcal Polysaccharide Vaccine, with price, sales, revenue and global market share of Meningococcal Polysaccharide Vaccine from 2019 to 2024.
Chapter 3, the Meningococcal Polysaccharide Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meningococcal Polysaccharide Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Meningococcal Polysaccharide Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Meningococcal Polysaccharide Vaccine.
Chapter 14 and 15, to describe Meningococcal Polysaccharide Vaccine sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Meningococcal Polysaccharide Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Meningococcal Polysaccharide Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Polysaccharide Meningtitis AC
1.3.3 Meningitis ACYW
1.4 Market Analysis by Application
1.4.1 Overview: Global Meningococcal Polysaccharide Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 6 Months-15Year
1.4.3 over 3 Year
1.4.4 over 2 Year
1.4.5 over 3 Months
1.5 Global Meningococcal Polysaccharide Vaccine Market Size & Forecast
1.5.1 Global Meningococcal Polysaccharide Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Meningococcal Polysaccharide Vaccine Sales Quantity (2019-2030)
1.5.3 Global Meningococcal Polysaccharide Vaccine Average Price (2019-2030)
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Meningococcal Polysaccharide Vaccine Product and Services
2.1.4 Sanofi Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Recent Developments/Updates
2.2 Bio-Med
2.2.1 Bio-Med Details
2.2.2 Bio-Med Major Business
2.2.3 Bio-Med Meningococcal Polysaccharide Vaccine Product and Services
2.2.4 Bio-Med Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bio-Med Recent Developments/Updates
2.3 CanSinoBIO
2.3.1 CanSinoBIO Details
2.3.2 CanSinoBIO Major Business
2.3.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
2.3.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 CanSinoBIO Recent Developments/Updates
2.4 Walvax Biotechnology
2.4.1 Walvax Biotechnology Details
2.4.2 Walvax Biotechnology Major Business
2.4.3 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
2.4.4 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Walvax Biotechnology Recent Developments/Updates
2.5 Chongqing Zhifei Biological
2.5.1 Chongqing Zhifei Biological Details
2.5.2 Chongqing Zhifei Biological Major Business
2.5.3 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Product and Services
2.5.4 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Chongqing Zhifei Biological Recent Developments/Updates
2.6 Chengdu Kanghua Biological Products
2.6.1 Chengdu Kanghua Biological Products Details
2.6.2 Chengdu Kanghua Biological Products Major Business
2.6.3 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Product and Services
2.6.4 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Chengdu Kanghua Biological Products Recent Developments/Updates
2.7 Changsheng Biotechnology
2.7.1 Changsheng Biotechnology Details
2.7.2 Changsheng Biotechnology Major Business
2.7.3 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
2.7.4 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Changsheng Biotechnology Recent Developments/Updates
2.8 CanSinoBIO
2.8.1 CanSinoBIO Details
2.8.2 CanSinoBIO Major Business
2.8.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
2.8.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 CanSinoBIO Recent Developments/Updates
3.1 Global Meningococcal Polysaccharide Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Meningococcal Polysaccharide Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Meningococcal Polysaccharide Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Meningococcal Polysaccharide Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Meningococcal Polysaccharide Vaccine Manufacturer Market Share in 2023
3.5 Meningococcal Polysaccharide Vaccine Market: Overall Company Footprint Analysis
3.5.1 Meningococcal Polysaccharide Vaccine Market: Region Footprint
3.5.2 Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
3.5.3 Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Meningococcal Polysaccharide Vaccine Market Size by Region
4.1.1 Global Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Meningococcal Polysaccharide Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Meningococcal Polysaccharide Vaccine Average Price by Region (2019-2030)
4.2 North America Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030)
4.3 Europe Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030)
4.5 South America Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030)
5.1 Global Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Meningococcal Polysaccharide Vaccine Consumption Value by Type (2019-2030)
5.3 Global Meningococcal Polysaccharide Vaccine Average Price by Type (2019-2030)
6.1 Global Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Meningococcal Polysaccharide Vaccine Consumption Value by Application (2019-2030)
6.3 Global Meningococcal Polysaccharide Vaccine Average Price by Application (2019-2030)
7.1 North America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Meningococcal Polysaccharide Vaccine Market Size by Country
7.3.1 North America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Meningococcal Polysaccharide Vaccine Market Size by Country
8.3.1 Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Meningococcal Polysaccharide Vaccine Market Size by Region
9.3.1 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Meningococcal Polysaccharide Vaccine Market Size by Country
10.3.1 South America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Meningococcal Polysaccharide Vaccine Market Size by Country
11.3.1 Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Meningococcal Polysaccharide Vaccine Market Drivers
12.2 Meningococcal Polysaccharide Vaccine Market Restraints
12.3 Meningococcal Polysaccharide Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Meningococcal Polysaccharide Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Meningococcal Polysaccharide Vaccine
13.3 Meningococcal Polysaccharide Vaccine Production Process
13.4 Meningococcal Polysaccharide Vaccine Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Meningococcal Polysaccharide Vaccine Typical Distributors
14.3 Meningococcal Polysaccharide Vaccine Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Meningococcal Polysaccharide Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Meningococcal Polysaccharide Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Meningococcal Polysaccharide Vaccine Product and Services
Table 6. Sanofi Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sanofi Recent Developments/Updates
Table 8. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 9. Bio-Med Major Business
Table 10. Bio-Med Meningococcal Polysaccharide Vaccine Product and Services
Table 11. Bio-Med Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Bio-Med Recent Developments/Updates
Table 13. CanSinoBIO Basic Information, Manufacturing Base and Competitors
Table 14. CanSinoBIO Major Business
Table 15. CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
Table 16. CanSinoBIO Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. CanSinoBIO Recent Developments/Updates
Table 18. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 19. Walvax Biotechnology Major Business
Table 20. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
Table 21. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Walvax Biotechnology Recent Developments/Updates
Table 23. Chongqing Zhifei Biological Basic Information, Manufacturing Base and Competitors
Table 24. Chongqing Zhifei Biological Major Business
Table 25. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Product and Services
Table 26. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Chongqing Zhifei Biological Recent Developments/Updates
Table 28. Chengdu Kanghua Biological Products Basic Information, Manufacturing Base and Competitors
Table 29. Chengdu Kanghua Biological Products Major Business
Table 30. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Product and Services
Table 31. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Chengdu Kanghua Biological Products Recent Developments/Updates
Table 33. Changsheng Biotechnology Basic Information, Manufacturing Base and Competitors
Table 34. Changsheng Biotechnology Major Business
Table 35. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
Table 36. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Changsheng Biotechnology Recent Developments/Updates
Table 38. CanSinoBIO Basic Information, Manufacturing Base and Competitors
Table 39. CanSinoBIO Major Business
Table 40. CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
Table 41. CanSinoBIO Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. CanSinoBIO Recent Developments/Updates
Table 43. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Doses)
Table 44. Global Meningococcal Polysaccharide Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 45. Global Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2019-2024) & (US$/Dose)
Table 46. Market Position of Manufacturers in Meningococcal Polysaccharide Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 47. Head Office and Meningococcal Polysaccharide Vaccine Production Site of Key Manufacturer
Table 48. Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
Table 49. Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
Table 50. Meningococcal Polysaccharide Vaccine New Market Entrants and Barriers to Market Entry
Table 51. Meningococcal Polysaccharide Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 53. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 54. Global Meningococcal Polysaccharide Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 55. Global Meningococcal Polysaccharide Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 56. Global Meningococcal Polysaccharide Vaccine Average Price by Region (2019-2024) & (US$/Dose)
Table 57. Global Meningococcal Polysaccharide Vaccine Average Price by Region (2025-2030) & (US$/Dose)
Table 58. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 59. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 60. Global Meningococcal Polysaccharide Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 61. Global Meningococcal Polysaccharide Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 62. Global Meningococcal Polysaccharide Vaccine Average Price by Type (2019-2024) & (US$/Dose)
Table 63. Global Meningococcal Polysaccharide Vaccine Average Price by Type (2025-2030) & (US$/Dose)
Table 64. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 65. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 66. Global Meningococcal Polysaccharide Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 67. Global Meningococcal Polysaccharide Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 68. Global Meningococcal Polysaccharide Vaccine Average Price by Application (2019-2024) & (US$/Dose)
Table 69. Global Meningococcal Polysaccharide Vaccine Average Price by Application (2025-2030) & (US$/Dose)
Table 70. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 71. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 72. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 73. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 74. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 75. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 76. North America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 77. North America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 78. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 79. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 80. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 81. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 82. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 83. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 84. Europe Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Meningococcal Polysaccharide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 87. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 88. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 89. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 90. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 91. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 92. Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 93. Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 94. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 95. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 96. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 97. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 98. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 99. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 100. South America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 101. South America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 103. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 104. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 105. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 106. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 107. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 108. Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 109. Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 110. Meningococcal Polysaccharide Vaccine Raw Material
Table 111. Key Manufacturers of Meningococcal Polysaccharide Vaccine Raw Materials
Table 112. Meningococcal Polysaccharide Vaccine Typical Distributors
Table 113. Meningococcal Polysaccharide Vaccine Typical Customers
List of Figures
Figure 1. Meningococcal Polysaccharide Vaccine Picture
Figure 2. Global Meningococcal Polysaccharide Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Polysaccharide Meningtitis AC Examples
Figure 5. Meningitis ACYW Examples
Figure 6. Global Meningococcal Polysaccharide Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Application in 2023
Figure 8. 6 Months-15Year Examples
Figure 9. over 3 Year Examples
Figure 10. over 2 Year Examples
Figure 11. over 3 Months Examples
Figure 12. Global Meningococcal Polysaccharide Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Meningococcal Polysaccharide Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Meningococcal Polysaccharide Vaccine Sales Quantity (2019-2030) & (K Doses)
Figure 15. Global Meningococcal Polysaccharide Vaccine Average Price (2019-2030) & (US$/Dose)
Figure 16. Global Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Meningococcal Polysaccharide Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Meningococcal Polysaccharide Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Meningococcal Polysaccharide Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Meningococcal Polysaccharide Vaccine Average Price by Type (2019-2030) & (US$/Dose)
Figure 31. Global Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Meningococcal Polysaccharide Vaccine Average Price by Application (2019-2030) & (US$/Dose)
Figure 34. North America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 54. China Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Meningococcal Polysaccharide Vaccine Market Drivers
Figure 75. Meningococcal Polysaccharide Vaccine Market Restraints
Figure 76. Meningococcal Polysaccharide Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Meningococcal Polysaccharide Vaccine in 2023
Figure 79. Manufacturing Process Analysis of Meningococcal Polysaccharide Vaccine
Figure 80. Meningococcal Polysaccharide Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Sanofi Bio-Med CanSinoBIO Walvax Biotechnology Chongqing Zhifei Biological Chengdu Kanghua Biological Products Changsheng Biotechnology CanSinoBIO
Related Reports
27 Feb 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
